Insmed (INSM) Misses Q2 EPS by 40c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $127.25 -2.61%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q2 EPS of ($1.70), $0.40 worse than the analyst estimate of ($1.30). Revenue for the quarter came in at $107.4 million versus the consensus estimate of $103.41 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Musalem: strong growth and investment influencing bond market - CNBC
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Arctos agrees to buy 10% of Atlanta Falcons at $10.6 billion valuation - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
